Efficacy of the de novo-derived antimicrobial peptide WLBU2 against oral bacteria

Karen F. Novak, William J. Diamond, Sreenatha Kirakodu, Rebecca Peyyala, Kimberly W. Anderson, Ronald C. Montelaro, Timothy A. Mietzner

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

The efficacy of a novel synthetic antimicrobial peptide (WLBU2) was evaluated against three oral microorganisms (grown planktonically): Streptococcus gordonii, Fusobacterium nucleatum, and Porphyromonas gingivalis. WLBU2 killed all three species, with F. nucleatum being the most susceptible. WLBU2 also reduced the bacterial burden of S. gordonii and F. nucleatum biofilms.

Original languageEnglish
Pages (from-to)1837-1839
Number of pages3
JournalAntimicrobial Agents and Chemotherapy
Volume51
Issue number5
DOIs
StatePublished - May 2007

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Efficacy of the de novo-derived antimicrobial peptide WLBU2 against oral bacteria'. Together they form a unique fingerprint.

Cite this